about
Thrombin-activatable fibrinolysis inhibitor activity in healthy and diseased dogs.Clinical accuracy of point-of-care urine culture in general practicePoint of care susceptibility testing in primary care - does it lead to a more appropriate prescription of antibiotics in patients with uncomplicated urinary tract infections? Protocol for a randomized controlled trial.Optimization and evaluation of Flexicult® Vet for detection, identification and antimicrobial susceptibility testing of bacterial uropathogens in small animal veterinary practiceExploring the feasibility and synergistic value of the One Health approach in clinical research: protocol for a prospective observational study of diagnostic pathways in human and canine patients with suspected urinary tract infection.Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats.Effect of antibiotic treatment in canine and feline urinary tract infections: a systematic review.Quantitative assessment of faecal shedding of β-lactam-resistant Escherichia coli and enterococci in dogs.Evaluation of different sampling methods and criteria for diagnosing canine urinary tract infection by quantitative bacterial culture.Effect of point-of-care susceptibility testing in general practice on appropriate prescription of antibiotics for patients with uncomplicated urinary tract infection: a diagnostic randomised controlled trial.Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.Cross-sectional survey on the use and impact of the Danish national antibiotic use guidelines for companion animal practice.Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis.Effects of Diagnostic Work-Up on Medical Decision-Making for Canine Urinary Tract Infection: An Observational Study in Danish Small Animal Practices.Reviewing the evidence: Feline diabetic remissionCirculating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas - a prospective studyInvestigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogsEvaluation of Human Recombinant Tissue Factor-Activated Thromboelastography in 49 Dogs with NeoplasiaDiversity of Staphylococcus pseudintermedius in carriage sites and skin lesions of dogs with superficial bacterial folliculitis: potential implications for diagnostic testing and therapySubclinical bacteriuria in a mixed population of 179 middle-aged and elderly cats: a prospective cross-sectional studyCardiac troponin I in cats with compromised renal functionStability and profiling of urinary microRNAs in healthy cats and cats with pyelonephritis or other urological conditionsImpact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiotaPre-test probability of urinary tract infection in dogs with clinical signs of lower urinary tract diseaseInternational Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats
P50
Q33389702-EF5CF936-DDEC-47A0-A8CF-D1A6C39BCE59Q33877676-A05C0688-ADDC-47E9-AA5C-E0B8A6ED4B45Q35751650-BE5A9941-4915-40FC-B44F-A828D53E6126Q36210766-3BA5C8F6-587D-4491-9417-A7E42595600BQ37498281-0C81D90C-188B-42B3-A993-25FFF1ABDE00Q38046968-496BBD78-CBD9-48FC-8177-1CAD26775A65Q38336984-5DBA6F51-5128-469C-BE80-E376DDD03F53Q40400957-B10B08C1-BC9D-48AE-80D1-6AD3B36D3D80Q40521858-395A74EE-5657-4FA7-8E3C-24A08D63FDF5Q42650198-CCAC364F-28FE-4F1E-9C1F-CAD839F20D65Q46243153-515088FE-AF9F-4447-A465-C04B3B6DEF30Q47094529-EFAABAF7-BB2E-4403-AB8A-2AC4DAE2668FQ47781348-50628E83-AD16-4D9E-9C8D-0633502B7959Q50577944-340A51A3-1628-405E-9B94-5AB8FA8374EBQ61463649-CBFF653A-59D2-4BFB-8B96-5F8B701C70F9Q61666590-4B15003B-C007-4138-BEE1-DBA30E581871Q62381911-8DC3A9B8-B7FA-4857-913A-36091F059418Q62381962-6C5FCAB6-220D-4C18-A5FF-E19776D38A16Q63761619-07C102C4-7B26-420B-9C91-050CCEB8A537Q90180929-C950B61C-95AA-4062-A011-18BD380F1D8FQ90258912-B72A5CE8-EDA6-4886-B705-0D241087C4C8Q91266008-D95B35CB-43DC-4147-9667-76E0D4F3DFB7Q91505453-0D9DC40A-630F-4B48-A42F-0F46D9CCF535Q93010070-3050FEBE-94F5-4050-8C6B-713D73371F05Q93010086-4DC4F436-6870-4921-BB15-C8398AA603FE
P50
description
researcher ORCID ID = 0000-0002-9882-1637
@en
wetenschapper
@nl
name
Lisbeth Rem Jessen
@ast
Lisbeth Rem Jessen
@en
Lisbeth Rem Jessen
@es
Lisbeth Rem Jessen
@nl
type
label
Lisbeth Rem Jessen
@ast
Lisbeth Rem Jessen
@en
Lisbeth Rem Jessen
@es
Lisbeth Rem Jessen
@nl
prefLabel
Lisbeth Rem Jessen
@ast
Lisbeth Rem Jessen
@en
Lisbeth Rem Jessen
@es
Lisbeth Rem Jessen
@nl
P106
P214
8151533655502771707
P31
P496
0000-0002-9882-1637
P735
P7859
viaf-8151533655502771707